Study #2016-0847
Test-Retest of (18)F-Fluoroazomycin Arabinoside (18F,FAZA) PET-CT of Solid Tumors
MD Anderson Study Status
Not Accepting
Treatment Agent
Description
This early phase I trial studies how well 18F-fluoroazomycin arabinoside positron emission tomography (PET)-computed tomography (CT) works in diagnosing solid tumors. Using 18F-fluoroazomycin arabinoside with PET-CT may help doctors plan better treatment for patients with solid tumors. 18F-fluoroazomycin arabinoside may help to show how much oxygen is present in a tumor during a PET-CT scan.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Malignant Breast Neoplasm;Malignant Colorectal Neoplasm;Malignant Pancreatic Neoplasm;Malignant Solid Neoplasm
Study phase:
Phase I
Physician name:
Franklin Wong
Department:
Nuclear Medicine
For general questions about clinical trials:
1-877-582-0066
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.